US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

112 deals · US$144bndisclosed · Biotech · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Sep 2026 Marea Therapeutics –Lisata TherapeuticsAcquisitionAnnounced–Biotech+1 Goodwin (sell-side)
Sep 2026 Aethlon Medical ––MergerAnnounced–Biotech Gibson DunnMaxim GroupProcopio, Cory, Hargreaves & SavitchWedbush Securities
Sep 2026 Santersus AG –Xenetic BiosciencesAcquisitionAnnounced–Medtech+1 Mintz (sell-side)Lex Futura (sell-side)Holland & Knight (buy-side)Canaccord Genuity (buy-side)
Sep 2026 RIGImmune –Leyden LabsAcquisitionCompleted–Biotech+1 Gunderson Dettmer (sell-side)
Sep 2026 Polaris Demea AgroMotion Equity PartnersAcquisitionAnnounced–Food Ingredients+2 Goodwin (sell-side)
Sep 2026 Cellipont Bioservices ––MergerCompleted–Pharma Services+2 William Blair
Aug 2026 Merida Biosciences –Eli Lilly and CompanyAcquisitionAnnounced2,875.0Biotech+1 Goodwin (sell-side)Centerview Partners (sell-side)Ropes & Gray (buy-side)
Aug 2026 Ambros Therapeutics –Werewolf TherapeuticsMergerAnnounced500.0Biotech+2 Sidley Austin (buy-side)Cooley (sell-side)Piper Sandler (buy-side)
Aug 2026 Alesta Therapeutics –BioMarin PharmaceuticalAcquisitionAnnounced275.0Biotech+2 J.P. Morgan (sell-side)Goodwin (sell-side)NautaDutilh (sell-side)Morgan Stanley (buy-side)Jones Day (buy-side)
Aug 2026 Slate Medicines –Fulcrum TherapeuticsMergerAnnounced–Biotech+1 Goodwin (buy-side)Cooley (sell-side)Wedbush Securities (sell-side)Leerink Partners (buy-side)
Aug 2026 Redx Pharma –Skye BioscienceAcquisitionAnnounced–Biotech+1 Wedbush Securities (sell-side)Cooley (sell-side)Stifel (buy-side)Morrison & Foerster (buy-side)
Aug 2026 Actio Biosciences –Jazz PharmaceuticalsAcquisitionAnnounced820.0Biotech+2 J.P. Morgan (sell-side)Centerview Partners (sell-side)Cooley (sell-side)Moelis & Company (buy-side)Hogan Lovells Cadwalader (buy-side)
Aug 2026 assets, business operations and customer relationships –NueCell BioAsset saleAnnounced–Pharma Services+1 Goodwin (buy-side)
Aug 2026 Cy Biopharma –Ensysce BiosciencesAcquisitionCompleted–Biotech+1 H.C. Wainwright & Co.Orrick (sell-side)Wedbush Securities (sell-side)Troutman Pepper Locke (buy-side)Tungsten Advisors (buy-side)
Aug 2026 Alkeus Pharmaceuticals –Tarsus PharmaceuticalsAcquisitionAnnounced450.0Biotech+2 Jefferies (sell-side)Latham & Watkins (sell-side)Barclays (buy-side)Gunderson Dettmer (buy-side)
Aug 2026 MIMETAS –BRUKERAcquisitionCompleted–Life Sciences+1 Raymond James
Jul 2026 Neurimmune's royalty interest in AstraZeneca's cliramitug NeurimmuneRoyalty PharmaAsset saleAnnounced250.0Pharma+1 Goodwin (buy-side)
Jul 2026 Synlogic ––MergerAnnounced–Biotech+1 Lucid Capital Markets (sell-side)Mintz (sell-side)Fenwick & West (buy-side)
Jul 2026 Vidya Therapeutics –Processa PharmaceuticalsAcquisitionCompleted–Biotech+1 Leerink Partners (sell-side)Cooley (sell-side)Tungsten Advisors (buy-side)Katten Muchin Rosenman (buy-side)
Jul 2026 Forte Biosciences –argenx SEAcquisitionAnnounced2,200.0Biotech+1 Guggenheim Securities (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)Goldman Sachs (buy-side)Freshfields (buy-side)Innisfree M&A (buy-side)
Jul 2026 OHB Pediatrics Ltd. d/b/a Oak Hill Bio –Research Alliance Corporation IIIMergerAnnounced–Biotech+2 Goodwin (sell-side)Leerink Partners (buy-side)Cooley (buy-side)
Jul 2026 Neuphoria Therapeutics –Scancell HoldingsAcquisitionAnnounced–Biotech+1 H.C. Wainwright & Co. (sell-side)WG Partners (sell-side)Winston Taylor (sell-side)Leerink Partners (buy-side)Cooley (buy-side)
Jul 2026 BioLife Solutions –RepligenAcquisitionAnnounced1,500.0Life Sciences+1 Centerview Partners (sell-side)K&L Gates (sell-side)Goodwin (buy-side)Perella Weinberg Partners (buy-side)Goldman Sachs (buy-side)
Jul 2026 Avere Therapeutics –Hansoh Pharmaceutical Group Co.StakeAnnounced–Biotech+2 Goodwin (buy-side)
Jul 2026 AtaiBeckley –Eli Lilly and CompanyAcquisitionAnnounced2,800.0Biotech+2 Moelis & Company (sell-side)Centerview Partners (sell-side)Latham & Watkins (sell-side)Citi (sell-side)Cooley (sell-side)Sullivan & Cromwell (sell-side)Goldman Sachs (buy-side)Ropes & Gray (buy-side)
Jul 2026 Kira Pharmaceuticals –Jasper TherapeuticsAcquisitionCompleted–Biotech+1 Piper Sandler (sell-side)DLA Piper (sell-side)H.C. Wainwright & Co. (buy-side)Paul Hastings (buy-side)
Jul 2026 Senti Holdings, Inc. (Midco) Senti Biosciences HoldingsCeladon Partners SPV 35AcquisitionAnnounced–Biotech+2 Lincoln International (sell-side)Gunderson Dettmer (sell-side)McDermott Will & Schulte (buy-side)
Jul 2026 Avere Therapeutics –NextCureMergerAnnounced–Biotech+1 Sullivan & CromwellSidley Austin (buy-side)Gibson Dunn (sell-side)Wedbush Securities (sell-side)Tungsten Advisors (buy-side)
Jul 2026 iRenix Medical –Tarsus PharmaceuticalsAcquisitionAnnounced75.0Ophthalmology+2 Piper Sandler (sell-side)DLA Piper (sell-side)Gunderson Dettmer (buy-side)
Jul 2026 Crinetics Pharmaceuticals –Vertex PharmaceuticalsAcquisitionAnnounced10,000.0Biotech+2 Lazard (buy-side)J.P. Morgan (sell-side)Leerink Partners (sell-side)Paul, Weiss (sell-side)Morrison & Foerster (sell-side)Morgan Stanley (buy-side)Kirkland & Ellis (buy-side)
Jul 2026 BridgeBio –Sixth StreetStakeCompleted1,000.0Biotech+1 Sullivan & Cromwell (buy-side)Evercore (buy-side)
Jul 2026 Kestrel –AbbVieAcquisitionAnnounced–Biotech Lazard
Jul 2026 MeiraGTx Holdings –Oberland Capital ManagementStakeAnnounced–Biotech+1 Latham & Watkins (sell-side)
Jun 2026 Kartos Therapeutics –IpsenAcquisitionAnnounced450.0Biotech+1 Goldman Sachs (sell-side)PJT Partners (sell-side)DLA Piper (sell-side)Orrick (buy-side)
Jun 2026 Talawar Therapeutics –JATT II Acquisition CorpMergerAnnounced–Biotech+1 Cooley (sell-side)Greenberg Traurig (buy-side)
Jun 2026 Theravance Biopharma –ZymeworksAcquisitionPending929.0Pharma+1 Lazard (sell-side)Evercore (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Arthur Cox (sell-side)Kirkland & Ellis (buy-side)Matheson (buy-side)MTS Health Partners (buy-side)
Jun 2026 Remix Therapeutics –Passage BioMergerPending–Biotech+2 Wedbush SecuritiesRBC Capital MarketsCanaccord GenuityLatham & Watkins (sell-side)Fenwick & West (buy-side)
Jun 2026 Serapha Bio –Boundless BioMergerPending–Biotech+1 Wedbush Securities (sell-side)Gibson Dunn (sell-side)Goodwin (sell-side)Lucid Capital Markets (buy-side)Latham & Watkins (buy-side)
Jun 2026 Sangamo Therapeutics capsid delivery, zinc finger, modular integrase platforms and prion disease program Sangamo TherapeuticsEli Lilly and CompanyAsset saleCompleted–Biotech+1 Raymond JamesPaul, Weiss (buy-side)
Jun 2026 Apogee Therapeutics –AbbVieAcquisitionPending10,900.0Biotech+2 Goldman Sachs (sell-side)Jefferies (sell-side)Kirkland & Ellis (sell-side)Paul, Weiss (buy-side)Morgan Stanley (buy-side)
Jun 2026 4E Therapeutics –Eli Lilly and CompanyAcquisitionCompleted–Biotech+1 Wilson Sonsini Goodrich & Rosati (sell-side)
Jun 2026 Azora Therapeutics –Adial PharmaceuticalsAsset saleCompleted–Biotech+2 Lucid Capital Markets (sell-side)Honigman (sell-side)Oppenheimer & Co. (buy-side)Blank Rome (buy-side)
Jun 2026 Nuvalent –GSKAcquisitionPending10,600.0Biotech+2 Sullivan & CromwellCenterview Partners (sell-side)Ropes & Gray (sell-side)Jefferies (sell-side)Sidley Austin (sell-side)Leerink Partners (buy-side)Citi (buy-side)Davis Polk (buy-side)Slaughter and May (buy-side)Innisfree M&A (buy-side)
Jun 2026 Vega Therapeutics Star TherapeuticsIncyteAcquisitionCompleted1,250.0Biotech+2 Lazard (buy-side)Evercore (sell-side)Morgan Stanley (sell-side)Fenwick & West (sell-side)Goodwin (buy-side)
Jun 2026 Standard BioTools ––MergerPending460.0Biotech+2 Wedbush Securities (sell-side)Fenwick & West (sell-side)Centerview Partners (buy-side)Freshfields (buy-side)Richards, Layton & Finger (buy-side)UBS (buy-side)
Jun 2026 Genesis Molecular AI –IncyteStakeAnnounced40.0AI+1 Goodwin (buy-side)
Jun 2026 Avenzo Therapeutics –RallybioAcquisitionPending–Biotech+2 Leerink Partners (sell-side)Cooley (sell-side)Evercore (buy-side)Citizens JMP (buy-side)Ropes & Gray (buy-side)
Jun 2026 Sevasemten and Edgewise muscular dystrophy business Edgewise TherapeuticsServierAsset saleCompleted1,550.0Biotech+2 LazardCenterview Partners (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)
May 2026 Curevo Vaccine –Eli LillyAcquisitionPending1,500.0Biotech+1 Cooley (sell-side)Centerview Partners (sell-side)
May 2026 Vaccine Company –LillyAcquisitionAnnounced1,550.0Biotech+1 Lazard (sell-side)Cooley (sell-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built